GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axogen Inc (FRA:LT3) » Definitions » Cyclically Adjusted PB Ratio

Axogen (FRA:LT3) Cyclically Adjusted PB Ratio : 3.64 (As of Jun. 19, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Axogen Cyclically Adjusted PB Ratio?

As of today (2024-06-19), Axogen's current share price is €6.80. Axogen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €1.87. Axogen's Cyclically Adjusted PB Ratio for today is 3.64.

The historical rank and industry rank for Axogen's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:LT3' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.93   Med: 13.27   Max: 160.47
Current: 3.44

During the past years, Axogen's highest Cyclically Adjusted PB Ratio was 160.47. The lowest was 1.93. And the median was 13.27.

FRA:LT3's Cyclically Adjusted PB Ratio is ranked worse than
69.25% of 478 companies
in the Medical Devices & Instruments industry
Industry Median: 2.03 vs FRA:LT3: 3.44

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Axogen's adjusted book value per share data for the three months ended in Mar. 2024 was €1.962. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.87 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Axogen Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Axogen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axogen Cyclically Adjusted PB Ratio Chart

Axogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.20 15.19 6.96 6.01 3.45

Axogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.36 4.89 2.59 3.45 3.89

Competitive Comparison of Axogen's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Axogen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axogen's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Axogen's Cyclically Adjusted PB Ratio falls into.



Axogen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Axogen's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=6.80/1.87
=3.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Axogen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Axogen's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.962/131.7762*131.7762
=1.962

Current CPI (Mar. 2024) = 131.7762.

Axogen Quarterly Data

Book Value per Share CPI Adj_Book
201406 -0.302 100.560 -0.396
201409 -0.453 100.428 -0.594
201412 -0.468 99.070 -0.623
201503 -0.025 99.621 -0.033
201506 -0.126 100.684 -0.165
201509 0.334 100.392 0.438
201512 0.251 99.792 0.331
201603 0.145 100.470 0.190
201606 0.083 101.688 0.108
201609 0.033 101.861 0.043
201612 0.429 101.863 0.555
201703 0.343 102.862 0.439
201706 0.303 103.349 0.386
201709 0.265 104.136 0.335
201712 0.619 104.011 0.784
201803 0.507 105.290 0.635
201806 3.363 106.317 4.168
201809 3.313 106.507 4.099
201812 3.321 105.998 4.129
201903 3.183 107.251 3.911
201906 3.111 108.070 3.793
201909 3.116 108.329 3.790
201912 3.004 108.420 3.651
202003 2.828 108.902 3.422
202006 2.657 108.767 3.219
202009 2.575 109.815 3.090
202012 2.492 109.897 2.988
202103 2.462 111.754 2.903
202106 2.383 114.631 2.739
202109 2.358 115.734 2.685
202112 2.387 117.630 2.674
202203 2.247 121.301 2.441
202206 2.283 125.017 2.406
202209 2.424 125.227 2.551
202212 2.246 125.222 2.364
202303 2.127 127.348 2.201
202306 2.086 128.729 2.135
202309 2.129 129.860 2.160
202312 2.034 129.419 2.071
202403 1.962 131.776 1.962

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Axogen  (FRA:LT3) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Axogen Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Axogen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Axogen (FRA:LT3) Business Description

Traded in Other Exchanges
Address
13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Axogen (FRA:LT3) Headlines

No Headlines